These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 31178289)

  • 1. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.
    Clark A; van Zandvoort K; Flasche S; Sanderson C; Bines J; Tate J; Parashar U; Jit M
    Lancet Infect Dis; 2019 Jul; 19(7):717-727. PubMed ID: 31178289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.
    Isanaka S; Langendorf C; McNeal MM; Meyer N; Plikaytis B; Garba S; Sayinzoga-Makombe N; Soumana I; Guindo O; Makarimi R; Scherrer MF; Adehossi E; Ciglenecki I; Grais RF
    PLoS Med; 2021 Jul; 18(7):e1003655. PubMed ID: 34214095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.
    Zaman K; Dang DA; Victor JC; Shin S; Yunus M; Dallas MJ; Podder G; Vu DT; Le TP; Luby SP; Le HT; Coia ML; Lewis K; Rivers SB; Sack DA; Schödel F; Steele AD; Neuzil KM; Ciarlet M
    Lancet; 2010 Aug; 376(9741):615-23. PubMed ID: 20692031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.
    Armah GE; Sow SO; Breiman RF; Dallas MJ; Tapia MD; Feikin DR; Binka FN; Steele AD; Laserson KF; Ansah NA; Levine MM; Lewis K; Coia ML; Attah-Poku M; Ojwando J; Rivers SB; Victor JC; Nyambane G; Hodgson A; Schödel F; Ciarlet M; Neuzil KM
    Lancet; 2010 Aug; 376(9741):606-14. PubMed ID: 20692030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.
    Breiman RF; Zaman K; Armah G; Sow SO; Anh DD; Victor JC; Hille D; Ciarlet M; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1():A24-9. PubMed ID: 22520132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.
    Tapia MD; Armah G; Breiman RF; Dallas MJ; Lewis KD; Sow SO; Rivers SB; Levine MM; Laserson KF; Feikin DR; Victor JC; Ciarlet M; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A79-85. PubMed ID: 22520141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.
    Cunliffe NA; Witte D; Ngwira BM; Todd S; Bostock NJ; Turner AM; Chimpeni P; Victor JC; Steele AD; Bouckenooghe A; Neuzil KM
    Vaccine; 2012 Apr; 30 Suppl 1(0 1):A36-43. PubMed ID: 22520135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial.
    Madhi SA; Kirsten M; Louw C; Bos P; Aspinall S; Bouckenooghe A; Neuzil KM; Steele AD
    Vaccine; 2012 Apr; 30 Suppl 1():A44-51. PubMed ID: 22520136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Bergman H; Henschke N; Hungerford D; Pitan F; Ndwandwe D; Cunliffe N; Soares-Weiser K
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD008521. PubMed ID: 34788488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis.
    Burnett E; Parashar UD; Tate JE
    Lancet Glob Health; 2020 Sep; 8(9):e1195-e1202. PubMed ID: 32827481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines for preventing rotavirus diarrhoea: vaccines in use.
    Soares-Weiser K; Bergman H; Henschke N; Pitan F; Cunliffe N
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD008521. PubMed ID: 30912133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Experience With Rotavirus Vaccines.
    Burke RM; Tate JE; Parashar UD
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S792-S800. PubMed ID: 34374426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years: A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies.
    Sun ZW; Fu Y; Lu HL; Yang RX; Goyal H; Jiang Y; Xu HG
    JAMA Pediatr; 2021 Jul; 175(7):e210347. PubMed ID: 33970192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ORVAC trial protocol: a phase IV, double-blind, randomised, placebo-controlled clinical trial of a third scheduled dose of Rotarix rotavirus vaccine in Australian Indigenous infants to improve protection against gastroenteritis.
    Middleton BF; Jones MA; Waddington CS; Danchin M; McCallum C; Gallagher S; Leach AJ; Andrews R; Kirkwood C; Cunliffe N; Carapetis J; Marsh JA; Snelling T
    BMJ Open; 2019 Nov; 9(11):e032549. PubMed ID: 31727664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentavalent rotavirus vaccine (RotaTeq): a review of its use in the prevention of rotavirus gastroenteritis in Europe.
    Plosker GL
    Drugs; 2010 Jun; 70(9):1165-88. PubMed ID: 20518582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.
    Vesikari T; Karvonen A; Prymula R; Schuster V; Tejedor JC; Cohen R; Meurice F; Han HH; Damaso S; Bouckenooghe A
    Lancet; 2007 Nov; 370(9601):1757-63. PubMed ID: 18037080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postvaccination Serum Antirotavirus Immunoglobulin A as a Correlate of Protection Against Rotavirus Gastroenteritis Across Settings.
    Baker JM; Tate JE; Leon J; Haber MJ; Pitzer VE; Lopman BA
    J Infect Dis; 2020 Jun; 222(2):309-318. PubMed ID: 32060525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.